Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 2 |
Descriptor
Autism | 2 |
Behavior Change | 2 |
Children | 2 |
Control Groups | 2 |
Experimental Groups | 2 |
Outcomes of Treatment | 2 |
Symptoms (Individual… | 2 |
Academic Achievement | 1 |
Adolescents | 1 |
Attention Control | 1 |
Check Lists | 1 |
More ▼ |
Source
Journal of Autism and… | 2 |
Author
Aman, Michael | 1 |
Hough, David | 1 |
Karcher, Keith | 1 |
Kent, Justine M. | 1 |
Kossyvaki, Lila | 1 |
Kushner, Stuart | 1 |
Mevorach, Carmel | 1 |
Ness, Seth | 1 |
Ning, Xiaoping | 1 |
Shalev, Lilach | 1 |
Singh, Jaskaran | 1 |
More ▼ |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Elementary Education | 1 |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Aberrant Behavior Checklist | 1 |
Obsessive Compulsive Scale | 1 |
What Works Clearinghouse Rating
Spaniol, Mayra Muller; Shalev, Lilach; Kossyvaki, Lila; Mevorach, Carmel – Journal of Autism and Developmental Disorders, 2018
This study assessed the effectiveness of an attention intervention program (Computerized Progressive Attentional Training; CPAT) in improving academic performance of children with ASD. Fifteen 6-10 year olds with ASD attending a mainstream and a special school were assigned to an experimental (CPAT; n = 8) and active control (computer games; n =…
Descriptors: Attention Control, Training, Autism, Pervasive Developmental Disorders
Kent, Justine M.; Kushner, Stuart; Ning, Xiaoping; Karcher, Keith; Ness, Seth; Aman, Michael; Singh, Jaskaran; Hough, David – Journal of Autism and Developmental Disorders, 2013
Efficacy and safety of 2 risperidone doses were evaluated in children and adolescents with autism. Patients (N = 96; 5-17 years), received risperidone (low-dose: 0.125 mg/day [20 to <45 kg], 0.175 mg/day [>45 kg] or high-dose: 1.25 mg/day [20 to <45 kg], 1.75 mg/day [>45 kg]) or placebo. Mean baseline (range 27-29) to endpoint change…
Descriptors: Drug Therapy, Children, Adolescents, Autism